What is the market size of neurodegenerative disease | Trends & Growth Analysis 2026

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10864

Publication Date: Nov 2025

What is the size of Neurodegenerative Disease Market?

According to 6Wresearch internal database and industry insights, the Global Neurodegenerative Disease Treatment Market was valued at USD 12 Billion in 2025 and is expected to reach USD 16.5 Billion by 2032, growing at a compound annual growth rate of 5% during the forecast period (2026-2032).

There are numbers of factors which are contributing in the expansion of the market include rising prevalence of neurodegenerative disorders such as Alzheimer and Parkinson, increasing geriatric population, advancements in diagnostic and therapeutic technologies, and growing investments in drug development and research.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Neurodegenerative Disease Treatment Market.

View Main Report Schedule Analyst Call

Key Growth Drivers of the Neurodegenerative Disease Market

Rising incidence of Alzheimer, Parkinson, and ALS
Increasing aging population requiring advanced therapies
Development of novel drugs and biologics for neurodegenerative conditions
Adoption of advanced diagnostics and biomarker-based solutions
Growing healthcare expenditure in neurological disease management
Expanding research and clinical trials in neurodegenerative therapies

Neurodegenerative Disease Market Trends

Neurodegenerative Disease Market is witnessing significant growth with trends such as development of targeted therapies and biologics for Alzheimer and Parkinson. Use of artificial intelligence and digital tools for early diagnosis and monitoring is increasing. Integration of personalized medicine approaches is rising. Growth in neuroprotective drug development and regenerative medicine is observed. Adoption of minimally invasive and non-invasive diagnostic methods is increasing. Expansion in telehealth and remote patient monitoring for neurological care is notable. Investments in patient support programs and disease awareness campaigns are growing. Collaboration between pharmaceutical and biotech companies is accelerating market expansion.

Emerging Developments in the Neurodegenerative Disease Market

Neurodegenerative Disease Market is evolving with advancements in gene therapy, stem cell therapy, and disease-modifying drugs. The market has seen more research and development in precision medicine and new biomarkers for early detection. More clinical trials are focusing on new ways to treat diseases. More research institutions, pharmaceutical companies, and biotech companies are working together. More people are using advanced imaging and AI-based diagnostic tools. The development of new drugs that target neuroinflammation and protein aggregation is still going on. Growth is being driven by the rise of patient-centered care models and digital therapeutics. Funding from both the government and private sources is helping to support new ideas in neurological research.